When.com Web Search

  1. Ads

    related to: g3 boat value

Search results

  1. Results From The WOW.Com Content Network
  2. USS G-3 - Wikipedia

    en.wikipedia.org/wiki/USS_G-3

    The latter took place off Eaton's Point, Long Island, on 8 February, with Simon Lake – owner of the Lake Torpedo Boat Company – embarked. The boat successfully completed a test dive to 198 ft (60 m) and was preliminarily accepted by the Navy that same day. On 11 February, G-3 proceeded to New London, Connecticut, for initial shakedown ...

  3. Brunswick Boat Group - Wikipedia

    en.wikipedia.org/wiki/Brunswick_Boat_Group

    The Brunswick Boat Group is an American pleasure boat manufacturer. Headquartered in Knoxville, Tennessee , United States , it is the largest maker of such craft in the world. Net sales were US$ 1.7 billion in 2008, [ 2 ] and US$ 1.0 billion in 2012.

  4. Gulfstream III - Wikipedia

    en.wikipedia.org/wiki/Gulfstream_III

    The Gulfstream III was built at Savannah, Georgia, in the United States and was designed as an improved variant of the Grumman Gulfstream II.Design studies were performed by Grumman Aerospace Corporation in collaboration with Gulfstream American Corporation.

  5. Boat loans for older boats vs. new boats: What you need to know

    www.aol.com/finance/boat-loans-older-boats-vs...

    Like new cars, new boats lose value quickly, which makes used boats less attractive for lenders. It may be more difficult to finance an older boat, unless you choose an unsecured loan.

  6. G3 - Wikipedia

    en.wikipedia.org/wiki/G3

    G3 power state, in computer ACPI power states; G3, a fax encoding format; G3, a PBX from the Avaya Definity range; Gibson G3, a 1975 bass guitar; iAudio G3, an mp3 player from the Cowon iAudio range; Panasonic Lumix DMC-G3, a digital interchangeable lens camera made by Panasonic; PowerPC G3, a microprocessor branding used by Apple Computer

  7. Tariff threats, drug pricing will be 2 key pharma issues ...

    www.aol.com/finance/tariff-threats-drug-pricing...

    Drug pricing is the final key issue facing the health sector in 2025, but analysts expect this won't actually come to a head until 2027.